Hephaistos is a medical imaging software design company created in September 2019 that participates in the development of artificial intelligence in the field of health. Hephasistos, through artificial intelligence, aims to make cancer screening easier and simpler...

We were quickly able to benefit from the recognition of the digital world, Indeed in December 2019 and February 2020, the project led by Hephaistos was recognized as innovative and rewarded in the "Startup contest"-competition placed under the high patronage of the President of France-Emmanuel Macron-and during the 'Dreaminnov'. Thus, in December 2020, the company finalized a first software allowing pathologists to visualize digitized tissue biopsies and to prepare their report. In the first quarter of 2021, the company finalized a second software. Its function is to assist pathologists in decision-making in the context of breast cancer diagnosis. Finally the last project will aim to provide assistance in brest cancer screening. This involves the design of a nomadic device allowing the first diagnostic phase to be carried out under optimal conditions

Read more

We were quickly able to benefit from the recognition of the digital world. Indeed in December 2019 and February 2020, the project led by Hephaistos was recognized as innovative and rewarded in the “ Startup contest” – competition placed under the high patronage of the President of France – Emmanuel Macron – and during the “ Dreaminnov’. Héphaïstos has a range of three products:• Evna: the social network bringing together all the players involved in the fight against cancer (this goes from doctors to associations fighting against cancer)• Romy: the universal viewer which allows Pathologistes to discover the structure of a biopsy, to do documentar y research, statistics and visualization. This tool is intended for pathologists• Mai: the first mobile device in the world to carry out the first phase of breast cancer diagnosis in clinic, general medicine and sickbay

We were quickly able to benefit from the recognition of the digital world. Indeed in December 2019 and February 2020, the project led by Hephaistos was recognized as innovative and rewarded in the “ Startup contest” – competition placed under the high patronage of the President of France – Emmanuel Macron – and during the “ Dreaminnov’. Héphaïstos has a range of three products:• Evna: the social network bringing together all the players involved in the fight against cancer (this goes from doctors to associations fighting against cancer)• Romy: the universal viewer which allows Pathologistes to discover the structure of a biopsy, to do documentar y research, statistics and visualization. This tool is intended for pathologists• Mai: the first mobile device in the world to carry out the first phase of breast cancer diagnosis in clinic, general medicine and sickbay